Schizophrenia Trial, Recruiting NCT05296720 Sponsor: Centre Psychothérapique de Nancy Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05296720
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female
  • People aged between 18 and 60 years old (inclusive)
  • People who have read, dated, and signed the consent form before any trial procedures begin (or whose legal guardian has done so, if applicable)
  • People who are enrolled in, or covered by, a social security plan

Who may not be able to join:

  • People who have a disorder related to the use of psychoactive substances, as defined by a standard medical diagnostic guide called the DSM-V
  • People who have recently used benzodiazepines (a type of medication), cannabis, or hallucinogenic substances within specific time windows before joining — cannabis use will be checked with a urine test (confirm with trial site for exact timeframes)
  • People who have a neurological condition or lasting effects from a past neurological problem
  • People who have Attention Deficit Hyperactivity Disorder (ADHD)
  • People who have borderline personality disorder
  • People who have significant sensory problems that affect daily functioning
  • People who are currently under court protection or are deprived of their liberty
  • Women who are pregnant, in labour, or currently breastfeeding
  • People who are currently participating in another clinical study that has a restriction on joining additional trials

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anne GIERSCH, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France

Phone: 0388116471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Psychothérapique de Nancy
Registry
ClinicalTrials.gov
Start date
13 April 2023
Est. completion
1 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

measure of movement speed

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov